Literature DB >> 2383962

Gadopentetate dimeglumine enhanced MRI in an anephric patient on dialysis.

P L Choyke1, J A Frank, D Webb, M R Filling-Katz.   

Abstract

Gadopentetate dimeglumine (Gd-DTPA) was injected into an anephric patient on maintenance haemodialysis. Sequential serum Gd levels before and after dialysis demonstrated incomplete removal of the administered dose. No clinical sequelae were observed. Gd-DTPA can be given to patients on dialysis, but like iodinated contrast media, may require more than one session for complete removal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383962     DOI: 10.1016/s0009-9260(05)80609-9

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  1 in total

1.  Dialyzability of gadodiamide in hemodialysis patients.

Authors:  Tomoya Saitoh; Kazumasa Hayasaka; Yoshiaki Tanaka; Tsutomu Kuno; Yuji Nagura
Journal:  Radiat Med       Date:  2006-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.